- Telehealth visits
- Insurance plan information
James L. Rubenstein, MD
Hematology and Medical Oncology • Hematology and Medical Oncology (Lymphoma)- Telehealth visits
- Insurance plan information
James L. Rubenstein, MD
Hematology and Medical Oncology • Hematology and Medical Oncology (Lymphoma)- Telehealth visits
- Insurance plan information
On this page
About me
Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body.
In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors.
Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology.
Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research.
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
Fellowship
- UCSF Medical Center - OMAG
Residency
- Stanford University School of Medicine
Internship
- Stanford University School of Medicine
Degree
- MD, Cornell University at Ithaca
Academic title
- Professor-in-Residence
My expertise
Specialties
- Hematology and Medical Oncology
- Hematology and Medical Oncology (Lymphoma)
Conditions
Locations
My research
Clinical trials
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS LymphomaOpens in a new window
Recruiting
The Common Terminology Criteria for Adverse Events (NCI CTCAE version 5.0) will be used to classify and graded any adverse events that occur after the particip...Tafasitamab Plus Lenalidomide in Relapsed CNS LymphomaOpens in a new window
Recruiting
Toxicities will be classified using the NCI Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The DLT will be based on the tolerability obser...
Publications
Showing 1-6 of 27 reviews
- July 16, 20265 out of 5 Stars
Dr Rubenstein is best Dr .not only professional but compassion, empathy, friendly.
- July 2, 20265 out of 5 Stars
Dr James Rubenstein is a caring compassionate clinician and highly knowledgeable researcher.
- June 20, 20265 out of 5 Stars
Grateful to have the high level of expertise and experience in Dr Rubenstein and his Fellows
- May 30, 20265 out of 5 Stars
Great experience and excellent care in complex condition
- April 16, 20265 out of 5 Stars
Dr. Rubinstein is special.
- February 11, 20265 out of 5 Stars
Care Provider was excellent in all areas, and I would highly recommend!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.